Resilience to expand capabilities at RTP facility

In addition to a planned $225 million investment in a Cincinnati facility to increase the site’s drug product capacity, Resilience plans to expand its drug product capabilities at the company’s Research Triangle Park facility using a modular design within its segregated expansion space to offer drug product manufacturing for multiple modalities, the company said.

Read More